IMMUNOGENICITY AND OTHER SAFETY PARAMETERS FOLLOWING MULTIPLE SC DOSES OF DASIGLUCAGON

Pieber, T; Ajala, B; Alassad, H; Steen, O; Dahl, D; White, J; Ge-Zerbe, L; Tehranchi, R

DIABETES TECHNOLOGY & THERAPEUTICS, 2020; 22 (): A188